Persistent URL of this record https://hdl.handle.net/1887/3181440
Documents
-
- Download
- 1-s2.0-S0025619619310055-main
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Renal impairment, cardiovascular disease, and the short-term efficacy and safety of PCSK9 targeted by inclisiran
- All authors
- Zijlstra, L.E.; Trompet, S.; Mooijaart, S.P.; Buren, M. van; Jukema, J.W.
- Date
- 2020-01-31
- Journal
- Mayo Clinic Proceedings
- Volume
- 95
- Issue
- 1
- Pages
- 12 - 14